Comparative Analysis of the Preventive Effects of Canagliflozin, a Sodium-Glucose Co-Transporter-2 Inhibitor, on Body Weight Gain Between Oral Gavage and Dietary Administration by Focusing on Fatty Acid Metabolism

PURPOSE: Sodium-glucose co-transporter-2 (SGLT2) inhibitors have various pleiotropic effects, including body weight reduction, and therefore have the potential to be used in various applications. However, such effects have not been fully investigated; thus, non-clinical studies using animal models a...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Diabetes Metab Syndr Obes
Main Authors: Kawarasaki, Satoko, Sawazaki, Honami, Iijima, Hiroaki, Ng, Su-Ping, Kwon, Jungin, Mohri, Shinsuke, Iwase, Mari, Jheng, Huei-Fen, Takahashi, Haruya, Nomura, Wataru, Inoue, Kazuo, Kawada, Teruo, Goto, Tsuyoshi
Format: Artigo
Jezik:Inglês
Izdano: Dove 2020
Teme:
Short Report
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7678695/
https://ncbi.nlm.nih.gov/pubmed/33235475
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DMSO.S269916
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki